Trump voices doubt on his drug czar nominee, the lead sponsor of a drugmaker-backed opioid bill

Rep. Tom Marino
(Image credit: Chip Somodevilla/Getty Images)

On Sunday night, 60 Minutes and The Washington Post reported that Rep. Tom Marino (R-Pa.) had worked for two years to push through a bill promoted and apparently written by the pharmaceutical industry that stripped the Drug Enforcement Administration of its biggest tool to fight prescription opioids entering the black market. Marino is President Trump's nominee to head the Office of National Drug Control Policy. On Monday, Trump called Marino "a good man," a "great guy," and "a very early supporter of mine — the great state of Pennsylvania," but said that after Sunday's 60 Minutes, "we're going to look into the report. We're going to take it very seriously."

Trump did not say if he would withdraw Marino's name to be drug czar, but hinted that he might. "I have not spoken to him, but I will speak to him, and I'll make that determination," he told reporters in the Rose Garden. "And if I think it's 1 percent negative to doing what we want to do, I will make a change, yes."

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Peter Weber, The Week US

Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.